PL344645A1 - Pth2 receptor selective compounds - Google Patents

Pth2 receptor selective compounds

Info

Publication number
PL344645A1
PL344645A1 PL99344645A PL34464599A PL344645A1 PL 344645 A1 PL344645 A1 PL 344645A1 PL 99344645 A PL99344645 A PL 99344645A PL 34464599 A PL34464599 A PL 34464599A PL 344645 A1 PL344645 A1 PL 344645A1
Authority
PL
Poland
Prior art keywords
selective compounds
receptor selective
abnormal
pth2 receptor
pth2
Prior art date
Application number
PL99344645A
Other languages
English (en)
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL344645A1 publication Critical patent/PL344645A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL99344645A 1998-05-05 1999-05-03 Pth2 receptor selective compounds PL344645A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05

Publications (1)

Publication Number Publication Date
PL344645A1 true PL344645A1 (en) 2001-11-19

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99344645A PL344645A1 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Country Status (12)

Country Link
US (2) US7531621B1 (cg-RX-API-DMAC7.html)
EP (1) EP1075491B1 (cg-RX-API-DMAC7.html)
JP (1) JP4460157B2 (cg-RX-API-DMAC7.html)
AT (1) ATE392431T1 (cg-RX-API-DMAC7.html)
AU (1) AU3673699A (cg-RX-API-DMAC7.html)
CA (1) CA2327509A1 (cg-RX-API-DMAC7.html)
DE (1) DE69938548T2 (cg-RX-API-DMAC7.html)
ES (1) ES2302374T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0300891A2 (cg-RX-API-DMAC7.html)
NO (1) NO20005556L (cg-RX-API-DMAC7.html)
PL (1) PL344645A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999057139A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ106299A3 (cs) 1996-09-26 1999-08-11 Chugai Seiyaku Kabushiki Kaisha Protilátky proti proteinu příbuznému s lidským parathyroidálním hormonem
WO1998051329A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Cachexia remedy
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
WO2001082968A1 (fr) 2000-04-28 2001-11-08 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation cellulaire
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
SI2084183T1 (sl) 2006-10-13 2010-09-30 Lilly Co Eli Pegilirani pth kot modulatorji pth receptorja in njihove uporabe
BRPI0814962B8 (pt) * 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
EP0341962B1 (en) 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1992011286A1 (en) * 1990-12-21 1992-07-09 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
AU3819497A (en) 1996-07-31 1998-02-20 General Hospital Corporation, The Novel parathyroid hormone-related peptide analogs

Also Published As

Publication number Publication date
JP2002513801A (ja) 2002-05-14
ATE392431T1 (de) 2008-05-15
HUP0300891A2 (hu) 2003-07-28
NO20005556D0 (no) 2000-11-03
WO1999057139A2 (en) 1999-11-11
CA2327509A1 (en) 1999-11-11
EP1075491A2 (en) 2001-02-14
DE69938548T2 (de) 2009-06-18
NO20005556L (no) 2001-01-03
DE69938548D1 (de) 2008-05-29
WO1999057139A3 (en) 2000-02-03
AU3673699A (en) 1999-11-23
US7531621B1 (en) 2009-05-12
JP4460157B2 (ja) 2010-05-12
EP1075491B1 (en) 2008-04-16
ES2302374T3 (es) 2008-07-01
US20090226477A1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
WO1999057139A3 (en) Pth2 receptor selective compounds
AU3652102A (en) Compounds and their uses
IL149890A0 (en) Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
WO2003105840A3 (en) Sphingosine kinase inhibitors
AU9393601A (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
BG108495A (en) 5-ht receptor ligands and uses thereof
IL109337A0 (en) Indole derivatives for use in migraine
IL156584A0 (en) Substituted triazole diamine derivatives as kinase inhibitors
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
IL164793A0 (en) Methods for increasing the therapeutic response toelectroconvulsive therapy ("ect")
YU2500A (sh) Alatrofloksacin parenteralni preparati
PL343411A1 (en) Novel compositions of eprosartan
GB9712966D0 (en) Novel chalcones
PL328709A1 (en) Mixture of dehydroepiandrosterone and aromatase inhibiting substances and application of such mixture in production of a therapeutic agent for treating relative and absolute hypoadrogenalaemia among male patients
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
MY118704A (en) Process for preparation of eprosartan
MY136343A (en) Peptides for treatment of cancer
MXPA04004844A (es) Tratamiento de hipertonia durante la fase aguda de un accidente cerebrobascular.
PL322253A1 (en) Application of antiestrogenes in controlling male fetrility
PL335501A1 (en) Quinoxalinodiones
WO2004010938A3 (en) Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure
TW200510374A (en) Benzimidazoles that are useful in treating sexual dysfunction

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)